-
4 Online Pharmacy Stocks To Play The Rising Demand For Home Prescription Delivery
Friday, November 20, 2020 - 12:08pm | 853Read More...Prescription delivery is one of the business sectors that's been spotlighted by the coronavirus pandemic. Even ahead of the pandemic, this space was seen as one with potential. Drugs are commodities, and pharma companies are defensive plays that tend to do well even during a downturn...
-
BofA Cuts Walgreens Earnings Estimate, Says Visibility Limited On Pharmacy Chain's Growth
Wednesday, August 26, 2020 - 11:30am | 541Read More...Walgreens Boots Alliance Inc (NASDAQ: WBA) has struggled in 2020, but its problems started well before the COVID-19 economic disruption. The stock is now down 52.3% over the last five years, and BofA Securities analyst Michael Cherny said Wednesday there’s little reason to expect...
-
Analyst Breaks Down CVS Health's 'Complicated' Quarter
Tuesday, August 11, 2020 - 12:31pm | 453Read More...CVS Health Corp's (NYSE: CVS) second-quarter earnings report can be defined as "more good than bad" yet the stock still trades at a discounted valuation, according to BofA Securities. The CVS Analyst: Michael Cherny maintains a Buy rating on CVS with an $80 price target. The...
-
2 Dow Stocks Surviving The Coronavirus Carnage
Monday, March 16, 2020 - 2:02pm | 354Read More...The Dow Jones Industrial Average came 400 points of falling to the 20,000 mark Monday, and even after a minor rebound, the index is still down a massive 2,000 points, or more than 9%. Two Dow components were standing out amid the wreckage: Caterpillar Inc. (NYSE: CAT) and Walgreens Boots...
-
Portfolio Manager Cole Smead Says Warren Buffett Is Watching Walgreens
Tuesday, November 26, 2019 - 2:25pm | 429Read More...Walgreens Boots Alliance Inc (NASDAQ: WBA) is reportedly evaluating an offer to sell itself to private equity giant KKR, and Warren Buffett could insert himself into the saga, a portfolio manager told CNBC Tuesday. Wall Street analysts and the financial media community are almost unified in...
-
A Closer Look At How A Walgreens Buyout Could Play Out
Thursday, November 14, 2019 - 10:20am | 368Read More...Pharmacy retail chain Walgreens Boots Alliance Inc (NASDAQ: WBA) closed Wednesday at a valuation of $55 billion, but it could be worth $85 billion under a leveraged buyout, according to Fox Business. Analyst Models $75-Per-Share Buyout Private equity giant KKR reportedly expressed interest in...
-
Diplomat Pharmacy Analysts Weigh Takeout Scenarios, Valuation After Going Concern Warning
Wednesday, November 13, 2019 - 4:25pm | 595Read More...Diplomat Pharmacy Inc (NYSE: DPLO) cautioned investors on Tuesday that it has "substantial doubts" related to its ability to continue functioning as a business. Some analysts aren't ready to throw in the towel just yet — and see upside after Tuesday's all-time lows...
-
Diplomat Pharmacy Has 'Substantial Doubt' It Can Continue Operations
Tuesday, November 12, 2019 - 2:11pm | 421Read More...Shares of Diplomat Pharmacy, Inc. (NYSE: DPLO), a Flint, Michigan-based independent provider of specialty pharmacy and infusion services, plummeted more than 50% Tuesday after the company warned investors it faces an existential threat. What Happened Diplomat reported third-quarter...
-
Rite Aid Reports Mixed Q2 Earnings, New CEO Says Pharmacy Chain 'Acting With Urgency'
Thursday, September 26, 2019 - 7:53am | 373Read More...Rite Aid Corporation (NYSE: RAD) reported second-quarter earnings of 12 cents per share on Thursday, beating the analyst consensus estimate of 7 cents by 71.43%. The company reported quarterly sales of $5.366 billion, missing the analyst consensus estimate of $5.41 billion by 0.81...
-
An 'Important Step': Rite Aid Names New CEO, Stock Inches Higher
Monday, August 12, 2019 - 8:31am | 432Read More...Shares of retail pharmacy Rite Aid Corporation (NYSE: RAD) gained 1.6% early Monday morning after naming digital shopping technology expert and health care industry veteran Heyward Donigan to its C-suite and board. What Happened Rite Aid said in early March that John Standley would tep down as...
-
Are CVS And Walgreens Unfairly Fighting Back Against Amazon's PillPack?
Wednesday, August 7, 2019 - 9:58am | 412Read More...E-commerce giant Amazon.com, Inc. (NASDAQ: AMZN) bought the online pharmacy company PillPack last year, and legacy pharmacy retailers may be unfairly fighting back, CNBC reported. PillPack offers a mail delivery service and offers consumers an alternative to traditional companies like CVS Health...
-
How CVS Wants To Be Less Like A Pharmacy Chain And More Like Amazon
Monday, August 5, 2019 - 8:23am | 355Read More...CVS Health Corp (NYSE: CVS) has a plan to be viewed less as a pharmacy chain and more like Amazon.com, Inc. (NASDAQ: AMZN) by selling annual memberships with free shipping. CVS has been testing a membership program called CarePass in Boston and the company is now ready to expand the initiative...
-
A Walgreens Analyst's Takeaways From Q3 Earnings
Friday, June 28, 2019 - 11:50am | 336Read More...Walgreens Boots Alliance Inc (NASDAQ: WBA) on Thursday reported fiscal third-quarter results, which prompted Wells Fargo to reaffirm a bullish stance. The Analyst Wells Fargo's Peter Costa maintains an Outperform rating on Walgreens with a $65 price target. The Thesis Walgreens reported an...
-
The 5 Most Expensive Drugs In US: What You Should Know
Sunday, June 23, 2019 - 3:56pm | 874Read More...The upward trajectory of prescription drug prices in the U.S. has drawn the ire of lawmakers. Prices of drugs are staggeringly high in the U.S. when compared to other developed countries such as Japan and in Europe. House lawmakers are discussing a plan that could work to curb high...
-
CNBC: Retail Pharmacies More Worried About Amazon Than They Admit
Friday, June 21, 2019 - 9:14am | 470Read More...Are traditional retail pharmacies and insurance companies worried about Amazon.com, Inc. (NASDAQ: AMZN)'s push into their respective territories? Public comments from management teams brush off any concerns, but actions taking place behind the scenes may suggest otherwise, according to CNBC....
